APA-viite

Gan, H. K., Kumthekar, P., Lassman, A. B., Merrell, R., van den Bent, M., Papadopoulos, K. P., . . . Reardon, D. A. (2015). ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY. Neuro Oncol.

Chicago-tyylinen lähdeviittaus

Gan, Hui K., et al. "ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY." Neuro Oncol 2015.

MLA-viite

Gan, Hui K., et al. "ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY." Neuro Oncol 2015.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.